Lin Hsin-Ching, Lin Pei-Wen, Su Chih-Ying, Chang Hsueh-Wen
Department of Otolaryngology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, No. 123, Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung Hsien, 833, Taiwan.
Laryngoscope. 2003 Apr;113(4):673-8. doi: 10.1097/00005537-200304000-00017.
OBJECTIVES/HYPOTHESIS: The ideal treatment for allergic rhinitis refractory to medical therapy is still lacking. The aim of the study is to evaluate the efficacy of turbinate surgery with radiofrequency for the treatment of allergic rhinitis that is unresponsive to medical therapy.
A prospective, nonrandomized clinical study.
From February 2000 to April 2002, 108 consecutive patients (45 men and 63 women [mean age, 29.5 y]) with allergic rhinitis refractory to medical therapy who underwent radiofrequency turbinate surgery were enrolled in the study. Postoperative follow-up ranged from 12 to 26 months. A standard 0-to-10 visual analogue scale with an anchor was used to assess the pain and the allergic symptoms, including nasal obstruction, rhinorrhea, sneezing, itchy nose, and itchy eyes, preoperatively and postoperatively at the end of weeks 1 and 2 and months 1, 3, 6, and 12 after surgery. Statistical analysis was determined by repeated measures of ANOVA.
None of the 108 patients had obvious discomfort other than mild numbness over the premaxillary area (24 of 108 [22.2%]) during operation. Also, no adverse reactions including bleeding, infection, adhesion, or a worsening of allergic symptoms were encountered. One hundred one patients were included in the final statistical analysis. Only nine patients reported no improvement at all after treatment. The response rate of radiofrequency turbinate surgery for allergic rhinitis refractory to medical therapy was 91.1% (92 of 101). At 1 year after the treatment, the degree of nasal obstruction had changed on the visual analogue scale (mean +/- SD) from 6.84 +/- 2.09 to 2.47 +/- 1.60, an improvement of 63.9%. The degree of rhinorrhea had changed from 5.74 +/- 2.75 to 2.57 +/- 2.31, an improvement of 55.2%. The degree of sneezing had changed from 5.30 +/- 2.80 to 2.59 +/- 2.13, an improvement of 51.1%. The degree of itchy nose had changed from 3.74 +/- 3.16 to 1.82 +/- 2.27, an improvement of 51.3%. The degree of itchy eyes had changed from 3.17 +/- 3.09 to 1.68 +/- 2.38, an improvement of 47.0%. The visual analogue scale scores for nasal obstruction, rhinorrhea, sneezing, itchy nose, and itchy eyes decreased significantly with time, from preoperative scores to scores at 1 year after surgery. Other additional effects and improvements, including headache, lumpy throat, night cough, and tinnitus, were also reported by the patients. Most of the patients stated that they would consider repeating this procedure if necessary and would recommend the new method to their friends with the same problems.
The study demonstrates that radiofrequency appears to be an effective and safe tool for treating allergic rhinitis with poor response to medical therapy. In the future, radiofrequency has the potential to be one of the most popular surgical modalities for the treatment of allergic rhinitis refractory to medical therapy.
目的/假设:目前仍缺乏针对药物治疗无效的过敏性鼻炎的理想治疗方法。本研究旨在评估射频下鼻甲手术治疗对药物治疗无反应的过敏性鼻炎的疗效。
一项前瞻性、非随机临床研究。
2000年2月至2002年4月,108例连续接受射频下鼻甲手术的药物治疗无效的过敏性鼻炎患者(45例男性,63例女性[平均年龄29.5岁])纳入本研究。术后随访时间为12至26个月。采用标准的0至10分视觉模拟评分量表,在术前、术后第1周和第2周结束时以及术后1、3、6和12个月评估疼痛和过敏症状,包括鼻塞、流涕、打喷嚏、鼻痒和眼痒。采用重复测量方差分析进行统计分析。
108例患者中,无一例在手术期间除上颌前区轻度麻木(108例中的24例[22.2%])外有明显不适。此外,未出现包括出血、感染、粘连或过敏症状加重在内的不良反应。101例患者纳入最终统计分析。仅9例患者治疗后无改善。射频下鼻甲手术治疗药物治疗无效的过敏性鼻炎的有效率为91.1%(101例中的92例)。治疗1年后,视觉模拟评分量表上鼻塞程度(均值±标准差)从6.84±2.09改善至2.47±1.60,改善率为63.9%。流涕程度从5.74±2.75改善至2.57±2.31,改善率为55.2%。打喷嚏程度从5.30±2.80改善至2.59±2.13,改善率为51.1%。鼻痒程度从3.74±3.16改善至1.82±2.27,改善率为51.3%。眼痒程度从3.17±3.09改善至1.68±2.38,改善率为47.0%。鼻塞、流涕、打喷嚏、鼻痒和眼痒的视觉模拟评分量表评分随时间显著降低,从术前评分降至术后1年评分。患者还报告了其他额外的效果和改善,包括头痛、咽部异物感、夜间咳嗽和耳鸣。大多数患者表示如有必要会考虑重复该手术,并会向有相同问题的朋友推荐这种新方法。
本研究表明,射频似乎是治疗对药物治疗反应不佳的过敏性鼻炎的一种有效且安全的工具。未来,射频有可能成为治疗药物治疗无效的过敏性鼻炎最常用的手术方式之一。